NewcelX Announces New CFO Appointment Following Merger
I'm PortAI, I can summarize articles.
NewcelX Ltd. has appointed Mr. Omri Hagai as its new Chief Financial Officer, effective December 10, 2025, following the resignation of interim CFO Mr. Uri Ben Or. This change comes after the merger between NLS Pharmaceutics Ltd. and Kadimastem Ltd. Mr. Hagai's extensive experience in public companies is expected to enhance NewcelX's financial leadership. The company currently has a market cap of $2M and an average trading volume of 180,091.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments